| Pack Size | Qty | Lead Time | Price | Quantity |
Lot Number
CAS #
*This document is like a lab demo—an example Certificate of Analysis (COA) that showcases what a COA looks like but may not match the latest batch in all its glory. Think of it as a chemistry experiment: close, but not quite the final reaction!
Share
Total BLR Stock
:
Bulk Quote| IUPAC name | 2-(methylamino)acetic acid |
| canonical smiles | CNCC(=O)O |
| inchi | InChI=1S/C3H7NO2/c1-4-2-3(5)6/h4H,2H2,1H3,(H,5,6) |
| inchi key | FSYKKLYZXJSNPZ-UHFFFAOYSA-N |
| molecular formula | C3H7NO2 |
| synonyms | |
| Compound Description |
| Molecular Weight: | 89.09 g/mol |
| XLogP3: | -2.8 |
| Hydrogen Bond Donor Count: | 2 |
| Hydrogen Bond Acceptor Count: | 3 |
| Rotatable Bond Count: | 2 |
| Exact Mass: | 89.047678466 g/mol |
| Monoisotopic Mass: | 89.047678466 g/mol |
| Topological Polar Surface Area: | 49.3 Ų |
| Heavy Atom Count: | 6 |
| Formal Charge: | 0 |
| Complexity: | 52.8 |
| Isotope Atom Count: | 0 |
| Defined Atom Stereocenter Count: | 0 |
| Undefined Atom Stereocenter Count: | 0 |
| Defined Bond Stereocenter Count: | 0 |
| Undefined Bond Stereocenter Count: | 0 |
| Covalently-Bonded Unit Count: | 1 |
| Compound Is Canonicalized: | Yes |
| Related Compounds |
| hazard signal | Warning |
| hazard classes and categories | |
| precautionary statement codes | P203, P264, P270, P280, P301+P317, P302+P352, P317, P318, P321, P330, P362+P364, P405, and P501 |
| hazard statements | |
| hazards summary | Causes analgesia in acute intravenous studies of mice. May cause irritation. |
| toxicity summary | Sarcosine is an oncometabolite. Sarcosine appears to upregulate the expression of the potent oncoprotein called human epidermal growth factor receptor 2 in androgen-dependent prostate cancer cells upon exposure to exogenous sarcosine. Thus, sarcosine may induce prostate cancer progression by increased HER2/neu expression. |
| symptoms | Acute Exposure: eye irritation and skin irritation Chronic Exposure: sarcosinemia is associated with mental delay, cardiomyopathy, deafness and visual disturbance. In individuals with prostate cancer, high prostate tissue levels of sarcosine promote aggressive, rapidly growing prostate tumors. |
| health effects | Acute Exposure: Can lead to eye and skin irritation. Chronic Exposure: High levels of sarcosine in prostate tissues are associated with aggressive prostate tumors. In this regard, sarcosine appears to function as an oncometabolite. High levels of sarcosine are also seen in patients with sarcosinemia. Sarcosinemia is a rare inborn error of metabolism that is characterized by an increased level of sarcosine in the plasma and urine. The enzymatic block results from a deficiency of sarcosine dehydrogenase , a liver mitochondrial matrix enzyme that converts sarcosine into glycine. The disease is mostly characterized by mental delay, cardiomyopathy, deafness and visual disturbance. |
| carcinogen classification | default_key: Not listed by IARC. Has been implicated in oncogenesis . |
